John P. Kelley, Director at ACORDA THERAPEUTICS INC (ACOR), sold 10,000 shares at $40.00 ($400K) on 2014-12-18, disclosed to the SEC on 2014-12-22.
Scheduled sale ($400k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MDCO | BUY | 2007-08-07 | $46K | — | Filing → |
| MDCO | SELL | 2007-01-05 | $1.6M | — | Filing → |